{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:36:43Z","timestamp":1770428203773,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.jaad.2004.10.862","type":"journal-article","created":{"date-parts":[[2005,3,4]],"date-time":"2005-03-04T10:04:06Z","timestamp":1109930646000},"page":"434-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Traditional systemic treatments have not fully met the needs of psoriasis patients: Results from a national survey"],"prefix":"10.1016","volume":"52","author":[{"given":"Tamar","family":"Nijsten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Rolstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.10.862_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2004.10.862_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(97)05257-4","article-title":"Psoriasis","volume":"350","author":"Stern","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.10.862_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1523-1747.2003.12145.x","article-title":"Randomized clinical trials for psoriasis 1977-2000: The EDEN survey","volume":"120","author":"Naldi","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib4","doi-asserted-by":"crossref","DOI":"10.1046\/j.1523-1747.2003.12152.x","article-title":"Resetting the research agenda for psoriasis","volume":"120","author":"Chalmers","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archderm.139.9.1195","article-title":"Applying trial evidence back to the patient","volume":"139","author":"Williams","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0895-4356(99)00225-5","article-title":"Evalauting the outcome of treatment. Shouldn't we be asking patients if they are better?","volume":"53","author":"Wright","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2004.10.862_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM199603283341306","article-title":"Assessment of quality-of-life outcomes","volume":"334","author":"Testa","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.10.862_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2753.2002.00372.x","article-title":"What criteria do patients use when judging the effectiveness of psoriasis management?","volume":"8","author":"Ersser","year":"2002","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.jaad.2004.10.862_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0895-4356(02)00602-9","article-title":"The metaphor of patients as customers. Implications for measuring satisfaction","volume":"56","author":"Hudak","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2004.10.862_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.282.12.1157","article-title":"Capturing the patient's view of change as a clinical outcome measure","volume":"282","author":"Fischer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.10.862_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaad.2004.10.862_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","article-title":"The effect of severe psoriasis on the quality of life of 369 patients","volume":"132","author":"Finlay","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/00031305.1997.10473961","article-title":"Packages for estimating finite mixtures: a review","volume":"51","author":"Haughton","year":"1997","journal-title":"Am Stat"},{"key":"10.1016\/j.jaad.2004.10.862_bib14","unstructured":"Boehning D, Schlattman P. Computer assisted analysis of mixtures (CAMAN). Available at: ftp.ukbf.fu-berlin.de\/sozmed\/caman.html. Accessed March 15, 2004."},{"key":"10.1016\/j.jaad.2004.10.862_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0190-9622(97)70210-X","article-title":"Development and validation of a quality of life instrument for cutaneous diseases","volume":"37","author":"Anderson","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.1997.tb01113.x","article-title":"Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress","volume":"137","author":"Fortune","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4400","article-title":"A systematic review of treatments for severe psoriasis","volume":"4","author":"Griffiths","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaad.2004.10.862_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/00015550152384254","article-title":"Treatment of psoriasis in the nordic countries: a questionnaire survey from 5739 members of the psoriasis associations","volume":"81","author":"Zachariae","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2004.10.862_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000018390","article-title":"Patient compliance and disease management in the treatment of psoriasis in the Netherlands","volume":"200","author":"Van de Kerkhof","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.10.862_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(02)00142-1","article-title":"A survey of psoriasis patients in Japan from 1982 to 2001","volume":"31","author":"Kawada","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2004.10.862_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1067\/mjd.2000.103983","article-title":"Clearance is not a realistic expectation of psoriasis treatment","volume":"42","author":"Al-Suwaian","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1067\/mjd.2002.120451","article-title":"Phototherapy utilization for psoriasis is declining in the United States","volume":"46","author":"Housman","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1067\/mjd.2001.112400","article-title":"Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study","volume":"44","author":"Ho","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1046\/j.1365-2133.1997.19902071.x","article-title":"A systematic review of five systemic therapies for severe psoriasis","volume":"137","author":"Spuls","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","article-title":"Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis","volume":"349","author":"Heydendael","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.10.862_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archderm.1995.01690170063009","article-title":"Assessing the preferences of patients with psoriasis. A quantitative, utility approach","volume":"131","author":"Zug","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1365-2133.2001.04183.x","article-title":"Quality of life and clinical outcome in psoriasis using intermittent cyclosporin","volume":"144","author":"Touw","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib28","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1001\/jama.290.23.3073","article-title":"Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial","volume":"290","author":"Gordon","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.10.862_bib29","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.10.862_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000069942","article-title":"Alefacept Clinical Study Group. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis","volume":"206","author":"Finlay","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.10.862_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2230.1993.tb02239.x","article-title":"The Psoriasis Disability Index-further analyes","volume":"18","author":"Kent","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib32","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.10.862_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0749-3797(99)00158-0","article-title":"Validation of self-reported chronic conditions and health services in a managed care population","volume":"18","author":"Martin","year":"2000","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jaad.2004.10.862_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1523-1747.ep12329912","article-title":"The self-administered psoriasis area and severity index is valid and reliable","volume":"106","author":"Feldman","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1477-7525-1-53","article-title":"Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials","volume":"1","author":"Shikiar","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaad.2004.10.862_bib36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0190-9622(97)80286-1","article-title":"Outcomes research: an overview","volume":"36","author":"Faust","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.141.1.19","article-title":"Members of the National Psoriasis Foundation have more extensive disease and are better informed with treatment options","author":"Nijsten","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.10.862_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0895-4356(99)00146-8","article-title":"Incorporating patient preferences into randomized trials","volume":"53","author":"Lambert","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2004.10.862_bib39","doi-asserted-by":"crossref","first-page":"II45","DOI":"10.1097\/00005650-200204001-00008","article-title":"Measuring clinically important changes with patient-oriented questionnaires","volume":"40","author":"Liang","year":"2002","journal-title":"Med Care"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204036345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204036345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:37:22Z","timestamp":1759268242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204036345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0190962204036345"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.10.862","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional systemic treatments have not fully met the needs of psoriasis patients: Results from a national survey","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.10.862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}